Loading clinical trials...
Loading clinical trials...
Study of eculizumab ability to correct the reperfusion injury of the kidney allograft.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Russian Academy of Medical Sciences
NCT04128189 · Kidney Transplant Recipient Response to Shingrix Vaccine, Kidney Failure, and more
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more
NCT07224763 · ESRD (End-Stage Renal Disease), Kidney Transplantation, and more
NCT06056102 · Kidney Transplant, Kidney Failure, and more
Russian Scientfic Center of Surgery
Moscow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions